BRPI0408209A - novas composições - Google Patents
novas composiçõesInfo
- Publication number
- BRPI0408209A BRPI0408209A BRPI0408209-5A BRPI0408209A BRPI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A BR PI0408209 A BRPI0408209 A BR PI0408209A
- Authority
- BR
- Brazil
- Prior art keywords
- new compositions
- formulations
- phenthine
- relates
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 abstract 2
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0305579.5A GB0305579D0 (en) | 2003-03-11 | 2003-03-11 | Pharmaceutical compositions |
| GB0328023A GB2399286A (en) | 2003-03-11 | 2003-12-03 | Sub-lingual fentanyl formulation |
| PCT/GB2004/001037 WO2004080382A2 (fr) | 2003-03-11 | 2004-03-11 | Nouvelles compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0408209A true BRPI0408209A (pt) | 2006-02-14 |
Family
ID=32992592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408209-5A BRPI0408209A (pt) | 2003-03-11 | 2004-03-11 | novas composições |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1608372A2 (fr) |
| JP (1) | JP2006519770A (fr) |
| KR (1) | KR20050115276A (fr) |
| AU (1) | AU2004218876B2 (fr) |
| BR (1) | BRPI0408209A (fr) |
| CA (1) | CA2516338A1 (fr) |
| MX (1) | MXPA05009602A (fr) |
| NO (1) | NO20054172L (fr) |
| NZ (1) | NZ541781A (fr) |
| WO (1) | WO2004080382A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097614B2 (en) * | 2005-02-17 | 2012-01-17 | Velcera Pharmaceuticals, Inc. | Transmucosal administration of meloxicam compositions for treating and preventing disorders in non-human domesticated animals |
| GB0514043D0 (en) * | 2005-07-08 | 2005-08-17 | Arakis Ltd | Fentanyl formulation |
| EP1976521B1 (fr) | 2006-01-25 | 2015-03-11 | Insys Therapeutics, Inc. | Pulvérisation sublinguale de fentanyle |
| PL2180844T3 (pl) | 2007-08-02 | 2018-07-31 | Insys Development Company, Inc. | Rozpylacz podjęzykowy z fentanylem |
| GB2476494A (en) * | 2009-12-24 | 2011-06-29 | Norwich Pharma Technologies Ltd | Formulation for the sublingual delivery of sufentanil |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE223202T1 (de) * | 1994-09-30 | 2002-09-15 | Mika Pharma Ges Fuer Die Entwi | Pharmazeutische zusammensetzung |
| US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| ES2293875T3 (es) * | 1997-10-01 | 2008-04-01 | Novadel Pharma Inc. | Aerosol bucal no polar. |
| SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
| US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
| WO2000047203A1 (fr) * | 1999-02-12 | 2000-08-17 | Mqs, Inc. | Formulation et systeme pour administration intra-orale de principes actifs |
| AU2001262992A1 (en) * | 2000-05-10 | 2002-02-18 | University Of Kentucky Research Foundation | System and method for intranasal administration of opioids |
| DE10064219B9 (de) * | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
-
2004
- 2004-03-11 CA CA002516338A patent/CA2516338A1/fr not_active Abandoned
- 2004-03-11 AU AU2004218876A patent/AU2004218876B2/en not_active Ceased
- 2004-03-11 EP EP04719527A patent/EP1608372A2/fr not_active Withdrawn
- 2004-03-11 BR BRPI0408209-5A patent/BRPI0408209A/pt not_active IP Right Cessation
- 2004-03-11 MX MXPA05009602A patent/MXPA05009602A/es not_active Application Discontinuation
- 2004-03-11 JP JP2006500257A patent/JP2006519770A/ja active Pending
- 2004-03-11 WO PCT/GB2004/001037 patent/WO2004080382A2/fr not_active Ceased
- 2004-03-11 KR KR1020057016853A patent/KR20050115276A/ko not_active Ceased
- 2004-03-11 NZ NZ541781A patent/NZ541781A/en unknown
-
2005
- 2005-09-07 NO NO20054172A patent/NO20054172L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ541781A (en) | 2008-04-30 |
| WO2004080382A3 (fr) | 2005-03-24 |
| WO2004080382A2 (fr) | 2004-09-23 |
| NO20054172L (no) | 2005-10-06 |
| CA2516338A1 (fr) | 2004-09-23 |
| AU2004218876B2 (en) | 2007-08-02 |
| KR20050115276A (ko) | 2005-12-07 |
| JP2006519770A (ja) | 2006-08-31 |
| EP1608372A2 (fr) | 2005-12-28 |
| AU2004218876A1 (en) | 2004-09-23 |
| MXPA05009602A (es) | 2005-11-08 |
| NO20054172D0 (no) | 2005-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL375874A1 (pl) | Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu | |
| CR7080A (es) | Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas. | |
| HRP20120323T1 (en) | Diarylhydantoin compounds | |
| HN2003000417A (es) | Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico | |
| BRPI0411916A (pt) | imidazoquinolinas substituìdas por sulfonamida | |
| DK1300398T3 (da) | Propan-1,3-dionderivat | |
| DE60205870D1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| BRPI0408895A (pt) | formulações de cladribina para administração oral e transmucosal aperfeiçoada | |
| CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
| BRPI0509184A (pt) | composições farmacêuticas | |
| IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
| SG133531A1 (en) | Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine | |
| ES2187261B2 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
| BR0212931A (pt) | Composição farmacêutica de liberação prolongada contendo metformina | |
| BR0208813A (pt) | Composições contendo imidazotriazinona para a aplicação nasal | |
| EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
| BRPI0412239A (pt) | sistemas emulsificantes contendo derivados de azetidina | |
| BRPI0408209A (pt) | novas composições | |
| BRPI0506779A (pt) | formulação de sorvete, e, sorvete | |
| GT200500358A (es) | Compuestos organicos | |
| MXPA06000636A (es) | Formulaciones semi-solidas para la administracion oral de taxoides. | |
| BRPI0409175A (pt) | preparação farmacêutica oral para antagonistas de bombeamento de próton | |
| BRPI0412737A (pt) | sistema semi-sólidos contendo derivados de azetidina | |
| HN2002000331A (es) | Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno | |
| MY137747A (en) | Nasal pharmaceutical piribedil composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |